v3.25.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Class A Common Stock
Common stock
Common stock
Class A Common Stock
Common stock
Class B Common Stock
Additional Pain-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Noncontrolling Interests
Stockholders' Equity, beginning balance (in shares) at Jan. 31, 2024       114,670,000 42,887,000        
Stockholders' Equity, beginning balance at Jan. 31, 2024 $ 606,392     $ 0 $ 0 $ 1,718,661 $ (1,161,288) $ 2,398 $ 46,621
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Conversion of stock (in shares)       19,855,000 (19,855,000)        
Issuance of common stock related to vested exercised stock options (in shares)         931,000        
Issuance of common stock related to vested exercised stock options 10,074         10,074      
Issuance of common stock under employee stock purchase plan (in shares)       252,000          
Issuance of common stock under employee stock purchase plan 7,932         7,932      
Issuance of common stock related to RSUs and PSUs vested (in shares)       1,565,000          
Charitable donation of common stock (in shares)   120,241   120,000          
Charitable donation of common stock 5,914 $ 5,900       5,914      
Vesting of early exercised stock options 189         189      
Stock-based compensation expense 91,221         91,425     (204)
Change in noncontrolling interest ownership           (409)     409
Other comprehensive loss (2,657)             (1,775) (882)
Net Income (loss) (43,239)           (42,321)   (918)
Stockholders' Equity, ending balance (in shares) at Jul. 31, 2024       136,462,000 23,963,000        
Stockholders' Equity, ending balance at Jul. 31, 2024 675,826     $ 0 $ 0 1,833,786 (1,203,609) 623 45,026
Stockholders' Equity, beginning balance (in shares) at Apr. 30, 2024       132,670,000 26,212,000        
Stockholders' Equity, beginning balance at Apr. 30, 2024 602,402     $ 0 $ 0 1,768,947 (1,216,521) 3,598 46,378
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Conversion of stock (in shares)       2,619,000 (2,619,000)        
Issuance of common stock related to vested exercised stock options (in shares)         370,000        
Issuance of common stock related to vested exercised stock options 4,981         4,981      
Issuance of common stock under employee stock purchase plan (in shares)       252,000          
Issuance of common stock under employee stock purchase plan 7,932         7,932      
Issuance of common stock related to RSUs and PSUs vested (in shares)       854,000          
Charitable donation of common stock (in shares)   67,015 67,000            
Charitable donation of common stock 2,957 $ 2,900       2,957      
Vesting of early exercised stock options 91         91      
Stock-based compensation expense 48,969         48,877     92
Change in noncontrolling interest ownership           1     (1)
Other comprehensive loss (3,743)             (2,975) (768)
Net Income (loss) 12,237           12,912   (675)
Stockholders' Equity, ending balance (in shares) at Jul. 31, 2024       136,462,000 23,963,000        
Stockholders' Equity, ending balance at Jul. 31, 2024 675,826     $ 0 $ 0 1,833,786 (1,203,609) 623 45,026
Stockholders' Equity, beginning balance (in shares) at Jan. 31, 2025       144,444,000 19,469,000        
Stockholders' Equity, beginning balance at Jan. 31, 2025 $ 821,306 [1]     $ 0 $ 0 1,952,031 (1,167,614) (8,508) 45,397
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Conversion of stock (in shares)       1,234,000 (1,234,000)        
Issuance of common stock related to vested exercised stock options (in shares) 642,000       642,000        
Issuance of common stock related to vested exercised stock options $ 7,289         7,289      
Issuance of common stock under employee stock purchase plan (in shares)       256,000          
Issuance of common stock under employee stock purchase plan 8,404         8,404      
Repurchases, net of early exercised stock options (in shares)         (1,000)        
Issuance of common stock related to RSUs and PSUs vested (in shares)       1,818,000          
Charitable donation of common stock (in shares)   81,778   82,000          
Charitable donation of common stock 3,526 $ 3,500       3,526      
Vesting of early exercised stock options 53         53      
Stock-based compensation expense 110,111         109,358     753
Change in noncontrolling interest ownership           98     (98)
Other comprehensive loss 7,147             6,997 150
Net Income (loss) (46,254)           (45,083)   (1,171)
Stockholders' Equity, ending balance (in shares) at Jul. 31, 2025       147,834,000 18,876,000        
Stockholders' Equity, ending balance at Jul. 31, 2025 911,582 [1]     $ 0 $ 0 2,080,759 (1,212,697) (1,511) 45,031
Stockholders' Equity, beginning balance (in shares) at Apr. 30, 2025       145,894,000 19,203,000        
Stockholders' Equity, beginning balance at Apr. 30, 2025 852,597     $ 0 $ 0 2,013,228 (1,203,489) (1,459) 44,317
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Conversion of stock (in shares)       612,000 (612,000)        
Issuance of common stock related to vested exercised stock options (in shares)         285,000        
Issuance of common stock related to vested exercised stock options 3,951         3,951      
Issuance of common stock under employee stock purchase plan (in shares)       256,000          
Issuance of common stock under employee stock purchase plan 8,404         8,404      
Issuance of common stock related to RSUs and PSUs vested (in shares)       1,031,000          
Charitable donation of common stock (in shares)   40,889 41,000            
Charitable donation of common stock 1,787 $ 1,800       1,787      
Vesting of early exercised stock options 15         15      
Stock-based compensation expense 54,284         53,374     910
Other comprehensive loss 540             (52) 592
Net Income (loss) (9,996)           (9,208)   (788)
Stockholders' Equity, ending balance (in shares) at Jul. 31, 2025       147,834,000 18,876,000        
Stockholders' Equity, ending balance at Jul. 31, 2025 $ 911,582 [1]     $ 0 $ 0 $ 2,080,759 $ (1,212,697) $ (1,511) $ 45,031
[1]
(1) As of July 31, 2025 and January 31, 2025, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $45.6 million and $46.5 million, respectively, and liabilities of $11.2 million and $10.3 million respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 10. Joint Venture” for further discussion.